Actinogen Medical Ltd (ACW) - Total Liabilities

Latest as of June 2025: AU$6.15 Million AUD ≈ $4.35 Million USD

Based on the latest financial reports, Actinogen Medical Ltd (ACW) has total liabilities worth AU$6.15 Million AUD (≈ $4.35 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Actinogen Medical Ltd - Total Liabilities Trend (2006–2025)

This chart illustrates how Actinogen Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Actinogen Medical Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Actinogen Medical Ltd Competitors by Total Liabilities

The table below lists competitors of Actinogen Medical Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
AGFA Gevaert NV BR:AGFB	Belgium	€1.00 Billion
Case Group AB ST:CASE	Sweden	Skr51.81 Million
WINS Co. Ltd KQ:136540	Korea	₩14.03 Billion
Space Shuttle Hi-Tech Co Ltd TW:2440	Taiwan	NT$1.28 Billion
Nurol Gayrimenkul Yatirim Ortakligi AS IS:NUGYO	Turkey	TL394.10 Million
Northern Technologies NASDAQ:NTIC	USA	$27.35 Million
Actic Group AB ST:ATIC	Sweden	Skr1.02 Billion
Pharmhouse Corp NASDAQ:PHSE	USA	$8.23 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Actinogen Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Actinogen Medical Ltd (ACW) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Actinogen Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Actinogen Medical Ltd (2006–2025)

The table below shows the annual total liabilities of Actinogen Medical Ltd from 2006 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$6.15 Million ≈ $4.35 Million	+280.42%
2024-06-30	AU$1.62 Million ≈ $1.14 Million	-10.34%
2023-06-30	AU$1.80 Million ≈ $1.27 Million	+15.01%
2022-06-30	AU$1.57 Million ≈ $1.11 Million	+70.21%
2021-06-30	AU$920.32K ≈ $651.19K	-12.16%
2020-06-30	AU$1.05 Million ≈ $741.29K	+87.96%
2019-06-30	AU$557.39K ≈ $394.39K	-27.45%
2018-06-30	AU$768.25K ≈ $543.59K	-9.00%
2017-06-30	AU$844.26K ≈ $597.37K	+2.43%
2016-06-30	AU$824.20K ≈ $583.18K	+270.20%
2015-06-30	AU$222.64K ≈ $157.53K	+345.93%
2014-06-30	AU$49.93K ≈ $35.33K	-38.60%
2013-06-30	AU$81.32K ≈ $57.54K	-31.55%
2012-06-30	AU$118.81K ≈ $84.06K	+25.48%
2011-06-30	AU$94.68K ≈ $66.99K	-45.45%
2010-06-30	AU$173.58K ≈ $122.82K	+64.66%
2009-06-30	AU$105.42K ≈ $74.59K	+28.04%
2008-06-30	AU$82.33K ≈ $58.26K	+37.22%
2007-06-30	AU$60.00K ≈ $42.45K	+106.90%
2006-06-30	AU$29.00K ≈ $20.52K	--

About Actinogen Medical Ltd

AU:ACW Australia Biotechnology

Market Cap

$76.47 Million

AU$108.07 Million AUD

Market Cap Rank

#20338 Global

#676 in Australia

Share Price

AU$0.03

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.07

All Time High

AU$0.18